Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapWebinarsCancer Summary SlidesMPN Symptom ManagementEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Navigating the Transition From Oncology Inpatient to Optimum Outpatient Care

      May 6, 2017
      By Lauren M. Green
      Article
      Conferences|ONS Annual Congress

      As presented at the 2017 ONS Annual Congress, nurses at Fox Chase Cancer Centers developed a process to improve their transition from inpatient to outpatient.

      Navigating the Transition From Oncology Inpatient to Optimum Outpatient Care

      Navigating the Transition From Oncology Inpatient to Optimum Outpatient Care

      Easing the transition from inpatient to outpatient care is an ongoing challenge for oncology practitioners. Post-discharge care can be fragmented, and patients—many of whom are older with comorbidities—can be especially vulnerable when handed off back to their community providers and other specialist care after leaving their cancer center with a complex set of discharge instructions.

      A team of nurses at Fox Chase Cancer Center sought to improve this process by optimizing care coordination with a more robust, multifaceted discharge planning process, and they shared their findings in a poster session at the 42nd Annual ONS Congress being held May 4-7 in Denver.

      Theresa Pody, MSN, RN, NE-BC, explained in an interview with Oncology Nursing News that because Fox Chase draws from a broad geographic area, care transitions can be particularly challenging. When patients go back to their community, it may be quite a distance away: “We did find that was one of the challenges—maintaining those relationships during discharge planning so nothing fell through the cracks, which often happens in a multidisciplinary, complex patient care setting.”

      To address this issue, Pody and colleagues initiated a system built around better communication and care coordination, and, importantly, an expanded role for an RN Transition Navigator to provide continuity between levels of care. Notably, the whole process—and the essential provider—patient discussions—starts early.

      Every day at Fox Chase, teams involving physicians, nurses, case managers, and sometimes social work and pharmacy, participate in multidisciplinary rounds. “We talk about the goals and plan for the day,” Pody said. “We also talk about when treatment will be completed, when the patient can go home, and if so, what needs to be set up. We also look at any medications that may need prior authorizations for, so the discharge isn’t delayed.”

      This is where the elevated navigator role comes in. “We also created a discharge navigator role who is involved in the rounding, so he/she gets to know the patient up front and will make the follow-up phone call that will happen later.” The navigator, already well-versed on the case, usually makes the call 24 to 48 hours after discharge, and has a computerized transitions and care summary at hand to guide the discussion that has a snapshot of the patient’s records and experience while at the hospital.

      In addition to patient-centered multidisciplinary rounds and the integration of the transition nurse navigator across the care continuum, Fox Chase developed an app to document all of the information communicated during the rounding process.

      “We used to have paper forms of discharge instructions, covering everything,” Pody explained. “They’re now part of one computer application, with checkboxes and a problem list specific to the patient that nurses complete, so nothing is really missed. We don’t have to remember everything, it’s all right there.”

      This document ultimately gets printed for the patient at discharge, along with a contact list with services provided at Fox Chase, emergency and outpatient clinic phone numbers, and a list of all services that could benefit the patient.

      The patient leaves with those instructions and a schedule of follow-up appointments. A list of medications and side effects is attached that’s very helpful for the patient, Pody added. “Sometimes they have a list of medications as long as my arm.” A nurse at Fox Chase set up an app that lives on their internal nursing web page detailing the drugs and side effects, so it’s easy for nurses to access when the time comes.

      Thus far, the program has been rated well in terms of patient satisfaction, as measured by answers to 2 custom questions the team added to the cancer center’s Press Ganey inpatient survey: 1 focused on the care coordination and transition process itself, and 1 about the follow up phone call.

      Another goal was to limit the number of phone calls after discharge. Fox Chase has a triage line for patient questions, and the number of calls to that line has decreased in the surgical unit where the transition program was piloted.

      Pody said that one of the toughest challenges when patients leave the hospital is making sure they go to the right point of care. “Sometimes they’re not strong enough to go home, even though they really want to. For us, to prevent them from coming back again, it’s about making sure that the next level of care post-discharge is appropriate for them.”

      Here again, she said, having a discharge navigator helps to identify if the patient needs transition to a different level of care, to a rehab facility, for example, or needs support at home.

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Photo of a woman wearing a blazer in front of an Oncology Nursing News backdrop
      Photo of a white man with curly hair and in front of a blue Oncology Nursing News backdrop
      Image of a woman with gray hair and glasses in front of a blue Oncology Nursing News background
      Photo of a woman with blond wavy hair wearing a blazer in front of a blue Oncology Nursing News background
      Photo of a woman with shoulder-length blond hair in front of an Oncology Nursing News backdrop
      Image of a woman with white hair in front of an Oncology Nursing News blue background
      Image of a man in a suit standing in front of a blue Oncology Nursing News backdrop
      Man in suit standing in front of blue watercolor Oncology Nursing News backdrop
      Image of a woman in front of a blue Oncology Nursing News-branded backdrop.
      Related Content

      Anatomical image of a person with the gastrointestinal tract highlighted

      Nivolumab/Ipilimumab To Be New MSI-H/dMMR mCRC Standard of Care

      Jordyn Sava
      June 12th 2025
      Article

      Lasting survival benefits vs chemotherapy or monotherapy were achieved with nivolumab and ipilimumab for patients MSI-H/ dMMR metastatic colorectal cancer.


      The Vitals

      Lauren Mahon Offers Nurse Perspectives on PARP Inhibitors As Ovarian Cancer Maintenance Therapy

      Lindsay Fischer
      June 15th 2023
      Podcast

      Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.


      Anatomical graphic of a kidney

      AI Tool May Predict Response, Resistance in Advanced RCC

      Kristie L. Kahl
      June 10th 2025
      Article

      A machine learning model applied to CheckMate 9ER may help predict outcomes and resistance in advanced renal cell carcinoma.


      The Vitals

      Seth Eisenberg Discusses New Methods of Reducing Hazardous Drug–Contaminated Toilet Aerosols in Hospital Setting

      Lindsay Fischer
      June 1st 2023
      Podcast

      Seth Eisenberg, ASN, RN, OCN, BMTCN, emphasizes the importance of reducing nurse exposure to hazardous drugs—and ongoing research efforts to improve nursing safety.


      Image of an anatomical figure on a desk of the female reproductive system

      Pembrolizumab Plus CCRT Could Become SOC in High-Risk Cervical Cancer

      Kristi Rosa
      June 8th 2025
      Article

      Final KEYNOTE-A18 results show sustained survival benefit with pembrolizumab plus concurrent chemoradiation in locally advanced cervical cancer.


      Graphic of blood cells

      Zilovertamab Vedotin Plus R-GemOx Shows Activity in R/R DLBCL

      Silas Inman
      June 7th 2025
      Article

      The ROR1-targeted ADC plus R-GemOx led to a 56.3% ORR in patients with relapsed or refractory diffuse large B-cell lymphoma in waveLINE-003.

      Related Content

      Anatomical image of a person with the gastrointestinal tract highlighted

      Nivolumab/Ipilimumab To Be New MSI-H/dMMR mCRC Standard of Care

      Jordyn Sava
      June 12th 2025
      Article

      Lasting survival benefits vs chemotherapy or monotherapy were achieved with nivolumab and ipilimumab for patients MSI-H/ dMMR metastatic colorectal cancer.


      The Vitals

      Lauren Mahon Offers Nurse Perspectives on PARP Inhibitors As Ovarian Cancer Maintenance Therapy

      Lindsay Fischer
      June 15th 2023
      Podcast

      Lauren Mahon, MSN, FNP-BC, breaks down what oncology nurses should know about PARP inhibitors in ovarian cancer.


      Anatomical graphic of a kidney

      AI Tool May Predict Response, Resistance in Advanced RCC

      Kristie L. Kahl
      June 10th 2025
      Article

      A machine learning model applied to CheckMate 9ER may help predict outcomes and resistance in advanced renal cell carcinoma.


      The Vitals

      Seth Eisenberg Discusses New Methods of Reducing Hazardous Drug–Contaminated Toilet Aerosols in Hospital Setting

      Lindsay Fischer
      June 1st 2023
      Podcast

      Seth Eisenberg, ASN, RN, OCN, BMTCN, emphasizes the importance of reducing nurse exposure to hazardous drugs—and ongoing research efforts to improve nursing safety.


      Image of an anatomical figure on a desk of the female reproductive system

      Pembrolizumab Plus CCRT Could Become SOC in High-Risk Cervical Cancer

      Kristi Rosa
      June 8th 2025
      Article

      Final KEYNOTE-A18 results show sustained survival benefit with pembrolizumab plus concurrent chemoradiation in locally advanced cervical cancer.


      Graphic of blood cells

      Zilovertamab Vedotin Plus R-GemOx Shows Activity in R/R DLBCL

      Silas Inman
      June 7th 2025
      Article

      The ROR1-targeted ADC plus R-GemOx led to a 56.3% ORR in patients with relapsed or refractory diffuse large B-cell lymphoma in waveLINE-003.

      Latest Conference Coverage

      Nivolumab/Ipilimumab To Be New MSI-H/dMMR mCRC Standard of Care

      T-DXd PFS Benefit Significant Across HR+, HER2-Low Breast Cancer Mutations

      AI Tool May Predict Response, Resistance in Advanced RCC

      Olanzapine May Reduce Nausea, Vomiting From Radiation

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      2 Commerce Drive
      Cranbury, NJ 08512

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.